FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
01-03-2020, 01:58 PM | #1 | |||
|
||||
Grand Magnate
|
Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C
Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C Orphazyme continues to have hope for efficacy of arimoclomol in Amyotrophic Lateral Sclerosis . . . : |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Cytokinetics Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension C | ALS News & Research | |||
IPX066 Open Label Extension Study | Parkinson's Disease Clinical Trials | |||
SYN115 Phase IIa; positive data | Parkinson's Disease Clinical Trials | |||
Teriflunomide: results of an open-label 144-week extension study | Multiple Sclerosis |